ArticleMolecular biotechnology2026
Application of Universal LNA Probe-Mediated Multiplex Real-Time PCR for the Detection of Antibiotic Resistance Genes.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The rising resistance of pathogens has increasingly complicated antibiotic treatments, leading to prolonged therapy durations and the potential for inadequate disease management. Current clinical methods (e.g., culture-based AST, conventional PCR, Sanger sequencing) for assessing microbial resistance are hampered by lengthy processing times, limited sensitivity, or high costs. In this study, we developed a multiplex quantitative polymerase chain reaction (qPCR) method using custom-designed universal locked nucleic acid (LNA) probes. This approach eliminates the need for target-specific fluorescent probes required in conventional qPCR assays, thereby offering broad applicability and reduced development costs. Using this method, a multiplex qPCR assay consisting of four tubes of four-plex reaction for the detection of 16 common antibiotic resistance genes (ARGs) was developed. These ARGs correspond to seven types of commonly used antibiotics and show high concordance with phenotypic resistance profiles. The established multiplex system demonstrated robust amplification performance, with a detection limit of 25 copies/μL for all targets. The analytical performance of this assay was validated in 172 samples from patients with severe pneumonia, achieving complete concordance with Sanger sequencing. Overall, this study provides an accurate, cost-effective, and rapid solution for detecting microbial resistance, enabling timely informed selection of antibiotics in clinical practice.
Indexed as
Identifiers
41102438What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.